Induction by antitumoral drugs of proteins that functionally complement CFTR: A novel therapy for cystic fibrosis? [2]

Lancet

Volumn 350, Issue 9079, 1997, Pages 711-712

  Lallemand, J Y ^b   Stoven, V ^a   Annereau, J P ^b   Boucher, J ^b   Blanquet, S ^b   Barthe, J ^b   Lenoir, G ^b  

^a ECOLE POLYTECHNIQUE   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; GLYCOPROTEIN P; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AMINO ACID SEQUENCE; CASE REPORT; CHEMOTHERAPY; CYSTIC FIBROSIS; FIBROSARCOMA; GENE DELETION; HUMAN; LETTER; MOUSE; PRIORITY JOURNAL;

EID: 0030775546     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63510-6     Document Type: Article

References (5)

1. Tommasini R, Evers R, Vogt E, et al. The human multidrug resistance-associated protein functionally complements the yeast cadmium resistance factor 1. Proc Natl Acad Sci USA 1996; 93: 6743-48.
2. Ruetz S, Brault M, Kast C, et al. Functional expression of the multidrug resistance-associated protein in yeast Saccharomyces cerevisiae. J Biol Chem 1996; 271: 4154-60.
3. Baranov VS, Ivaschenko T, Bakay B, et al. Proportion of the GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases. Hum Genet 1996; 97: 516-20.
4. 4 and structurally related conjugates. J Biol Chem 1994; 245: 27807-10.
5. Giaccone G, van Ark-Otte J, Rubio GJ, et al. MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs. Int J Cancer 1996; 66: 760-67.